Biochemical modulation of cytarabine triphosphate by clofarabineCOOPER, Todd; AYRES, Mary; NOWAK, Billie et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 4, pp 361-368, issn 0344-5704, 8 p.Article

Purification and characterization of an amidohydrolase for N⁴-long-chain fatty acyl derivatives of 1-β-D-arabinofuranosylcytosine from mouse liver microsomes = Purification et caractérisation d'une amidohydrolase par les dérivés N4 acyl de la 1-bêta-D-arabinofuranosylcytosine avec des acides gras à longue chaîne provenant des microsomes du foie de sourisHORI, K; TSURUO, T; TSUKAGOSHI, S et al.Cancer research (Baltimore). 1984, Vol 44, Num 3, pp 1187-1193, issn 0008-5472Article

EFFECT OF CYTOSINE ARABINOSIDE AND TWO OF ITS ANALOGUES ON HERPES SIMPLEX VIRUS TYPE 1 IN CELL CULTURESMATSUMOTO S; SUGANUMA T; ISHIDA N et al.1974; TOHOKU J. EXPER. MED.; JAP.; DA. 1974; VOL. 114; NO 4; PP. 393-394; BIBL. 3 REF.Article

Cerebrospinal fluid and plasma pharmacokinetics of high doses of 1-β-D-arabinofuranosylcytosine in nonhuman primates = Pharmacocinétique de fortes doses de 1-bêta-D-arabinofuranosyl cytosine dans le liquide céphalo-rachidien et le plasma chez les primates non humainsLOPEZ, J. A; BEARDSLEY, G. P; KRIKORIAN, J. G et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5190-5193, issn 0008-5472Article

Cytarabine-associated lymphoid dyscrasia with atypical T CD30+ infiltrate in a patient suffering from acute nonlymphoblastic leukaemiaPENATE, Y; GUILLERMO, N; HERNANDEZ-MACHIN, B et al.British journal of dermatology (1951). 2009, Vol 160, Num 5, pp 1122-1123, issn 0007-0963, 2 p.Article

In vitro sensitivity of various human tumors to 1-beta-D-arabinofuranosylcytosine and N⁴-behenoyl-1-beta-D-arabinofuranosylcytosineMAEHARA, Y; KUSUMOTO, T; KUSUMOTO, H et al.Chemotherapy (Basel). 1989, Vol 35, Num 3, pp 181-186, issn 0009-3157Article

Cytokinetic study on the effects of N⁴-behenoyl-1-β-D-arabinofuranosylcytosine on murine leukemic cells L 1210: a comparison with the effects of 1-β-D-arabinofuranosylcytosineMARUO, N; HORIUCHI, H; NAKABO, T et al.Hematological oncology. 1985, Vol 3, Num 1, pp 39-48, issn 0278-0232Article

Low-dose ARA-C fails to enhance differentiation of leukaemic cellsPERRI, R. T; WEISDORF, D. J; OKEN, M. M et al.British journal of haematology. 1985, Vol 59, Num 4, pp 697-701, issn 0007-1048Article

Potentiation of 1-β-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60 = Potentialisation du métabolisme et de la cytotoxicité de la 1-bêta-D-arabinofuranosylcytosine par le 2,3-dihydro-1H-imidazolo (1,2-b) pyrazole dans les cellules de leucémie promyélocytaire humaine, HL-60GRANT, S; BHALLA, K; RAUSCHER, F. III et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5093-5100, issn 0008-5472Article

Clinical pharmacology of N⁴-palmitoyl-1-β-D-arabinofuranosylcytosine in patients with hematologic malignanciesUEDA, T; NAKAMURA, T; KAGAWA, D et al.Cancer chemotherapy and pharmacology. 1989, Vol 24, Num 6, pp 371-375, issn 0344-5704Article

Contrôle d'uniformité de teneur des préparations injectables de Cytarabine = Quality control of injectable preparations containing cytarabine : détermination of cytarabine concentrationsCOLLIN, Cedric; CAMUS, Maryse; ALBOUSSIERE, Medhi et al.Le Pharmacien hospitalier. 2008, Vol 43, Num 172, pp 29-34, issn 0768-9179, 6 p.Article

Cell differentiation effects of 2'-fluoro-1-β-D-arabinofuranosyl pyrimidines in HL-60 cellsXIANG-BIN KONG; ANDREEFF, M; FANUCCHI, M. P et al.Leukemia research. 1987, Vol 11, Num 11, pp 1031-1039, issn 0145-2126Article

2.133.763 (B) (7213244). - 14AVRIL 1972. PROCEDE DE PRODUCTION DE LA 2,2-ANHYDRO-(1-BETA -D-ARABINOFURANOSYL)CYTOSINEsdPatent

Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosisCOLAGRANDE, Marianna; DI IANNI, Mauro; CIURNELLI, Raffaella et al.British journal of haematology. 2007, Vol 138, Num 6, pp 812-813, issn 0007-1048, 2 p.Article

Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside : The Taiwan experienceCHEN, Y.-C; LIN, S.-F; YAO, M et al.Seminars in hematology. 1996, Vol 33, Num 4, pp 30-34, issn 0037-1963, SUP3Conference Paper

Clinical laboratory identification of liposomal cytarabine in cerebrospinal fluidMANGRAVITI, Diane; GENZEN, Jonathan R.American journal of hematology. 2010, Vol 85, Num 6, pp 459-460, issn 0361-8609, 2 p.Article

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicityHARTFORD, Christine M; SHIWEI DUAN; DELANEY, Shannon M et al.Blood. 2009, Vol 113, Num 10, pp 2145-2153, issn 0006-4971, 9 p.Article

In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemiaHUBEEK, Isabelle; PETERS, Godefridus J; PIETERS, Rob et al.Haematologica (Roma). 2006, Vol 91, Num 1, pp 17-23, issn 0390-6078, 7 p.Article

TERATOGENIC EFFECTS OF THE PYRIMIDINE ANALOGUES 5-IODODEOXY-URIDINE AND CYTOSINE ARABINOSIDE IN LATE FETAL MICE AND RATS = EFFETS TERATOGENES DES IODO-5 DESOXYURIDINE ET CYTOSINE ARABINOSIDE, ANALOGUES DE LA PYRIMIDINE, CHEZ LES FOETUS AGES DE SOURIS ET DE RATPERCY DH.1975; TERATOLOGY; U.S.A.; DA. 1975; VOL. 11; NO 1; PP. 103-117; BIBL. 1 P.Article

Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosisSANCHO, Juan-Manuel; DEBEN, Guillermo; RIBERA, Josep-Maria et al.International journal of hematology. 2007, Vol 86, Num 1, pp 33-36, issn 0925-5710, 4 p.Article

The human equilibrative nucleoside transporter I mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemiaHUBEEK, I; STAM, R. W; KUIK, D. J et al.British journal of cancer. 2005, Vol 93, Num 12, pp 1388-1394, issn 0007-0920, 7 p.Article

PHARMACOLOGY OF 5'-ESTERS OF 1-BETA -D-ARABINOFURANOSYLCYTOSINE.HO DHW; NELL GL.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 6; PP. 1640-1643; BIBL. 20 REF.Article

UN CERTAIN ROLE OF CYTOSINE ARABINOSIDE IN VARICELLA INFECTION OF COMPROMISED HOSTS = ROLE INCERTAIN DE LA CYTOSINE ARABINOSIDE DANS L'INFECTION VARICELLEUSE DES HOTES A RISQUESTEVENS DA; MERIGAN TC.1972; J. PEDIATR.; U.S.A.; DA. 1972; VOL. 81; NO 3; PP. 562-565; BIBL. 8 REF.Serial Issue

2-chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndromeJABBOUR, Elias; VERSTOVSEK, Srdan; ANDREEFF, Michael et al.Cancer. 2005, Vol 104, Num 3, pp 541-546, issn 0008-543X, 6 p.Article

Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cellsOHTA, Takuya; HORI, Hmoki; OGAWA, Masahiro et al.Oncology reports. 2004, Vol 12, Num 5, pp 1115-1120, issn 1021-335X, 6 p.Article